Envision is a multi-modality workstation purpose-built for the small, more delicate subdermal layers of the periorbital region. It combines three complementary, programmable technologies: Forma-I bipolar radiofrequency (RF), Lumecca-I intense pulsed light (IPL), and Morpheus8 fractional RF microneedling, within one intelligent platform, allowing practitioners to address the underlying causes of Meibomian Gland Dysfunction (MGD), inflammatory dry eye disease, and ocular rosacea, while simultaneously rejuvenating the skin around the eyes.

The technology works synergistically. Forma-I delivers gentle, uniform bipolar RF energy to the eyelids and periorbital area, stimulating the meibomian glands to restore healthy oil production and relieve inflammation. Lumecca-I uses high-intensity, short-duration pulses of broadband light to interrupt the inflammatory cycle that drives ocular surface disease and to reduce vascular and pigmented lesions in the surrounding skin. Morpheus8 contributes minimally invasive fractional RF microneedling for collagen remodelling, tightening of crepey periorbital skin, and refinement of fine lines.

Each handpiece features small-size applicators and precise depth control, enabling safe, highly efficacious procedures in tissue zones where conventional devices cannot reach. At InMode, our UK device specialists work closely with each clinic to assess patient demographics, treatment goals, and existing technology, helping you determine whether Envision is the right strategic investment to expand into the rapidly growing ocular wellness and periorbital aesthetics market.